12-Jun-2026 19:06:11
DABUR : US FDA ISSUES IMPORT ALERT FOR SILVASSA PLANT ⚠️🇺🇸
• 🏭 US FDA inspected Dabur's Silvassa manufacturing facility and identified certain data integrity and maintenance-related observations • 📋 Company submitted responses to inspection observations received from the regulator • 🚫 US FDA has now issued an Import Alert (IA) 66-40 for drugs manufactured at the concerned facility • 📅 Import Alert was issued on June 10, 2026 following review of responses and inspection findings • ✅ Company clarified that there is no violation or contravention alleged • 📉 Dabur stated the order affects only a small part of the Silvassa facility related to private-label products and generates insignificant revenue • 🇮🇳 Domestic products are not impacted and the plant continues to remain operational • 🔧 Company is working with US FDA on corrective and preventive action plans and implementing alternate sourcing strategies for US customers 🔴 Impact: Negative (US FDA Import Alert may affect exports from the impacted facility, though management expects limited financial impact due to the small revenue contribution.)
DABUR INDIA LTD